Anesthesia News

Anesthesia

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Martin K et al. - Both antifibrinolytic drugs bear the risk of adverse outcome depending on the type of cardiac surgery. Administration of aprotinin should be avoided in coronary artery bypass graft and high risk patients, whereas administration of tranexamic acid is not recommended in valve surgery.


Previous Article Next Article

Today in Adverse Effects/Events...keeping you current

Digestive adverse effects due to sodium polystyrene sulfonate (Kayexalate) in dialysis patients
Néphrologie & Thérapeutique , 06/09/09

Refractory Anaphylactic Cardiac Arrest After Succinylcholine Administration
Anesthesia & Analgesia, 06/23/09

Venous Air Embolism during Total Laparoscopic Hysterectomy: Comparison to Total Abdominal Hysterectomy
Anesthesiology, 06/23/09

Today in Cardiothoracic...keeping you current

Management of venous thromboembolism in the intensive care unit
Journal of Critical Care, 06/11/09

Anaesthesia and coronary artery stents
Current Anaesthesia and Critical Care, 06/25/09

Dexmedetomidine suppresses the decrease in blood pressure during anesthetic induction and blunts the cardiovascular response to tracheal intubation
Journal of Clinical Anesthesia, 05/27/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address